← Leaderboards
Bonnie L. Blazer-Yost
Indiana University Indianapolis
$303,756
Attributed
$622,511
Total exposure
2
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $228.1K · FY2015–17$250K$187.5K$125K$62.5K$0
'15
'16
'17
Funding mix
By agency
FDA$592,511 · 1
NIH$30,000 · 1
By mechanism
R01$592,511 · 1
R13$30,000 · 1
Top collaborators
- Sharon M Moe3 shared
- Eric J Delpire1 shared
- Irena Levitan1 shared
- Hector Rasgado-Flores1 shared
Most similar at Indiana University Indianapolis
Same institution · by research overlap
- Sharon M Moe$24,308,038
- Andrew D Gavrin$966,763
- Sarah Elizabeth Wiehe$24,116,792
- Sylk Sotto$54,000
- Joseph Aloi$178,903
Others in their field
Top investigators on “Affect”
- Gerald T Nepom · Benaroya Research Inst At Virginia Mason$298,740,071
- Judith S. Currier · University Of California Los Angeles$287,585,588
- Chanza Baytop · Westat, Inc.$271,217,917
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$209,385,844
- David Heimbrook · Leidos Biomedical Research, Inc.$168,138,264
- Daniel R Kuritzkes · Brigham And Women'S Hospital$151,687,019
Research focus
AffectAmericanApoptosisAreaAutophagocytosisBaseBasic ScienceBiochemical ProcessBiogenesisBiological ProcessBiologyBrain DiseasesCardiovascular DiseasesCell MotilityCell ProliferationCellsCellular BiologyCellular MembraneCell VolumesCentral Nervous System DiseasesChicagoChronicCollaborationsAcute
Grant awards (4)
IND 117464 Use of Low Dose Pioglitazone to Treat Autosomal Dominant Polycystic Kidney Disease$194,799
R01 · FY2017 · FD
IND 117464 Use of Low Dose Pioglitazone to Treat Autosomal Dominant Polycystic Kidney Disease$198,120
R01 · FY2016 · FD
Cell Volume Regulation; Implications for Hydration and Nutrition in Health and Disease$30,000
R13 · FY2016 · HL
IND 117464 Use of Low Dose Pioglitazone to Treat Autosomal Dominant Polycystic Kidney Disease$199,592
R01 · FY2015 · FD